Stefan Verheye
Latest contributions
Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?
22 May 2025 – From EuroPCR 2025
Discover how the novel Hertz Contact Intravascular Lithotripsy (IVL) is pushing the boundaries of calcium modification in challenging coronary lesions.
This EuroPCR 2025 session shares real-world insights confirming the promising results of the PINNACLE I trial, with LithiX IVL proving safe and effective across eccentric, concentric, and...
LAA closure in challenging scenarios
22 May 2025 – From EuroPCR 2025
This session addresses the complexities of left atrial appendage (LAA) closure in challenging anatomical and clinical scenarios. Learn from compelling cases including management of incomplete surgical LAA ligation, closure of large and complex peridevice leaks, and navigating difficult anatomy in elderly patients. Emphasizing innovative techniques and...
Other coronary interventions: SSO2, angioPy & more
16 May 2024 – From EuroPCR 2024
This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....
Relief for the unrelievable: the role of the Reducer for refractory angina
15 May 2024 – From EuroPCR 2024
Explore the incidence and impact of refractory angina, observe a real-life Reducer implantation procedure with step-by-step analysis and discussions, gain insight into the coronary sinus mechanism of action and implantation techniques, grasp the indications for the Reducer, and review available clinical data in this session.
Cracking the calcium code - Novelty and utility of Hertz Contact intravascular lithotripsy
15 May 2024 – From EuroPCR 2024
Follow this session to learn about the novel HC-IVL system, its application for moderate to severe calcified lesions, and procedural tips. The LithiX Hertz Contact IVL addresses unmet needs in coronary artery calcification by offering a simplified workflow with fewer devices and effective treatment for difficult...
Robotic PCI: tips and tricks, challenging anatomies and future perspectives
14 May 2024 – From EuroPCR 2024
In this session, discover the effectiveness and safety of robotic PCI for both simple and complex lesions requiring additional devices like IVL, IVUS, laser, and FFR. Learn about the numerous benefits of robotics for patients and cathlab teams, including enhanced precision in wire navigation and stent...
Bioadaptor RCT 2 years: could we further improve long-term CAD outcomes vs DES?
14 May 2024 – From EuroPCR 2024
Follow this exchange between Antonio Colombo, Stefan Verheye, and Davide Capodanno as they discuss the past, present, and future of drug-eluting stents. They address the current limitations, emphasizing the issue of vessel caging, and suggest improvements, particularly highlighting the new Bioadaptor with uncaging bioresorbable elements that...
Restoring vessel physiology and function with Dynamx Bioadaptor - The holy grail of PCI
17 May 2023 – From EuroPCR 2023
Join this session to explore the revolutionary Dynamx Bioadaptor and its role in restoring vessel physiology and function. Learn about the specific patient and lesion characteristics that can be safely and effectively treated with this innovative device, gain confidence in the delivery and deployment techniques, understand...
Innovations in tricuspid valve therapies and complication management
17 May 2023 – From EuroPCR 2023
Discover here the cutting-edge techniques and breakthroughs that are reshaping the field of tricuspid valve therapies, while learning the art of effectively managing complications.
Management of complex non-culprit multivessel disease after STEMI - LIVE case
16 May 2023 – From EuroPCR 2023
Analyze the case of a 69-year-old non-diabetic male patient with mild chronic kidney disease, acute inferior MI and primary PCI on the postero-lateral RCA, whose angiography showed diffuse disease on the proximal CX and second OM (QFR: 0.65), and an intermediate prox LAD lesion (QFR: 0.90).
IVUS...
Coronary Sinus Reducer: insights into treating refractory angina patients with obstructive and non-obstructive coronary artery disease
16 May 2023 – From EuroPCR 2023
Watch this session to learn how Sinus Reducer may relieve angina by increasing pressure in the coronary sinus, and how it was associated with significant improvement in symptoms and quality of life, as long as the different steps of this simple procedure are dully followed and...
Robotic PCI: real-life experience with a new robotic platform
16 May 2023 – From EuroPCR 2023
The current problems in interventional cardiology have been the same for years: exposure to X-rays, or orthopaedic injuries to operators after decades in the cathlab. The solution to these problems could lie in robotics and the increasing use of artificial intelligence in practice. Follow this session...
How should I treat a patient with refractory angina using the Reducer Device?
22 Mar 2023
Watch the replay of this webinar on Coronary Interventions. You’ll learn all about '1st stent in left main PCI'
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
Robotic PCI: evolution or R-Evolution
19 May 2022 – From EuroPCR 2022
Consult this session including a recorded case, and learn more about robotic PCI - its benefits and recent clinical results. Discover what might be the future of robotic PCI.
Stents in challenging situations
18 May 2022 – From EuroPCR 2022
Watch this session to discover the use and outcome of a selection of abstract submissions concerning: the treatment of diffuse CAD with one long stent vs. multistents, novel uncaging bioadaptor for coronary revascularisation, one-month DAPT in high bleeding risk ACS patients and much more.
Start treating refractory angina patients with Reducer therapy - Practical aspects
17 May 2022 – From EuroPCR 2022
Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...
Long LAD lesion treated by Robotic PCI - Session with LIVE case
17 May 2022 – From EuroPCR 2022
Learn more about this active 65-year-old patient with previous TIA, de novo angina, hypertension, normal cognitive functions, and physical examination who will be treated live from Toulouse, France in this session!
Latest clinical evidence and practical aspects to start Reducer therapy in your centre
20 May 2021 – From EuroPCR 2021
Watch this session presented by Stefan Verheye, Francesco Giannini, Martine Gilard, Romain Didier, Tommaso Gori and Jonathan Hill in order to assess whether Reducer therapy can help your patients with refractory angina, to understand the tips and tricks of the Reducer implant, and to get a glimpse into...
Revascularisation strategies - PCR e-Course 2020 Hot lines
29 Jul 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.
PCR e-Course 2020 Late-Breaking Trials – part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- Crossover results from the RADIANCE-HTN SOLO trial
- DynamX Bioadaptor, a novel « uncaging » platform
- Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
Exploring evidence and experience with magnesium scaffold Magmaris
23 May 2019 – From EuroPCR 2019
Consult this session on magnesium scaffold Magmaris to learn more about the available data on its clinical use and to review interesting intravascular imaging data after Magmaris implantation.
DynamX Bioadaptor, the new frontier beyond stenting for PCI
22 May 2019 – From EuroPCR 2019
Consult this session on DynamX Bioadaptor to learn more about its technological advances and the early clinical trial results including QCA, IVUS and OCT imaging.
Latest generation DES - What do I need to know?
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the latest generation drug-eluting stents, such as the dynamX novolimus-eluting bioadaptor, and discover the results of various clinical trials: ANGIOLITE, DIRECT II, and more!
A proven evidence-based therapy when angina persists
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the growing problem of refractory angina, including microvascular angina and the alternatives to treat this challenging condition.
Bioresorbable scaffold: new data, new hope?
22 May 2019 – From EuroPCR 2019
Consult this session on bioresorbable scaffold (BRS) to learn about new data and clinical outcomes: FAMTOM II trial, BIOSOLVE-IV registry, and more!
